Trial Profile
Effects of Atorvastatin on Number and Function of Pro-inflammatory CD4+CD28null T-cells and Defective Treg in Patients with Acute Coronary Syndromes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Pravastatin
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 23 Oct 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 05 Aug 2011 New trial record